NCT02934009

Brief Summary

The determination of fluid status in dialysis patients is a major clinical problem. In this study the NMR-MOUSE is used to determine if it can be used to non-invasively determine hydration status of the skin. This evaluation will be performed in dialysis patients and healthy volunteers.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
31

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Oct 2016

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
terminated

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

September 30, 2016

Completed
1 day until next milestone

Study Start

First participant enrolled

October 1, 2016

Completed
13 days until next milestone

First Posted

Study publicly available on registry

October 14, 2016

Completed
3.6 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 8, 2020

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

May 8, 2020

Completed
Last Updated

March 24, 2021

Status Verified

March 1, 2021

Enrollment Period

3.6 years

First QC Date

September 30, 2016

Last Update Submit

March 23, 2021

Conditions

Outcome Measures

Primary Outcomes (1)

  • Measurement of the diffusion coefficient D [m²/s] by NMR-MOUSE in dialysis patients and healthy volunteers

    The skin will be subjected to a weak magnetic field (B0). The transversal relaxation time T2 \[in s\] will be measured stepwise in mm (millimeter) profiles for up to 16 mm depth in the skin. From the different measurements per profile of the skin a diffusion coefficient D \[m²/s\] will be calculated, which changes dependent on the hydration status of the skin.

    30 minutes

Secondary Outcomes (2)

  • Incidence of Treatment-Emergent Adverse Events [Safety and Tolerability] of NMR-Mouse dermal measurement

    30 minutes

  • Time needed for NMR-Mouse dermal measurement

    30 minutes

Study Arms (2)

Dialysis patients

EXPERIMENTAL

In this group dialysis patients are measured by NMR-Mobile Universal Surface Explorer® (NMR-Mouse) during their routine dialysis sessions. After a 5 min rest period the arm of the patients is placed onto the NMR-Mouse and measured before the beginning of dialysis. The arm examined is not the shunt arm. The area selected should not display any signs of skin disease or scars from previous surgeries. After the dialysis the same area is measured again in a second measurement. The measurement will be repeated on three different days with each patient.

Device: Dermal nuclear magnetic resonance (NMR)-profile measurement

Healthy volunteers

EXPERIMENTAL

In this group "kidney-healthy" volunteers will be examined by NMR-Mobile Universal Surface Explorer® (NMR-Mouse) at three different days. The right/left arm or leg will be used for repeated measurement. Altogether 2 measurements per day are reformed in order to evaluate the reproducibility and variability.

Device: Dermal nuclear magnetic resonance (NMR)-profile measurement

Interventions

Nuclear magnetic resonance (NMR)-profile measurement of the dermis

Also known as: NMR-MOUSE
Dialysis patientsHealthy volunteers

Eligibility Criteria

Age18 Years - 80 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Age 18-80
  • Dialysis
  • ability to perform NMR-measurement
  • Eligibility to sign informed consent
  • signed informed consent

You may not qualify if:

  • implanted cardiac device
  • implanted cranial device
  • implanted cochlea device
  • intrauterine device
  • other metallic implants
  • tattoo, any skin disease or scars from surgery (in the area of measurement)
  • previous skin treatment with cosmetics (of any kind) 24 hours prior to measurement
  • wearing of earrings, piercings or hearings-aids during measurement
  • participation in other clinical trials 30 days prior to participation in the SHN study
  • no written informed consent
  • any conditions, as determined by the examiner, that excludes the patient from participation in the study
  • subjects with legal guardian
  • subjects under employment or with any relation to the the sponsor or the investigator
  • participation in any other study

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University Hospital of RWTH Aachen, Department of Medicine II

Aachen, North Rhine-Westphalia, Germany

Location

Related Publications (5)

  • Perlo J, Casanova F, Blumich B. Profiles with microscopic resolution by single-sided NMR. J Magn Reson. 2005 Sep;176(1):64-70. doi: 10.1016/j.jmr.2005.05.017.

    PMID: 15975840BACKGROUND
  • Danieli E, Blumich B. Single-sided magnetic resonance profiling in biological and materials science. J Magn Reson. 2013 Apr;229:142-54. doi: 10.1016/j.jmr.2012.11.023. Epub 2012 Dec 8.

    PMID: 23290626BACKGROUND
  • Perlo J, Casanova F, Blumich B. Single-sided sensor for high-resolution NMR spectroscopy. J Magn Reson. 2006 Jun;180(2):274-9. doi: 10.1016/j.jmr.2006.03.004. Epub 2006 Mar 31.

    PMID: 16580238BACKGROUND
  • Medrano G, Eitner F, Floege J, Leonhardt S. A novel bioimpedance technique to monitor fluid volume state during hemodialysis treatment. ASAIO J. 2010 May-Jun;56(3):215-20. doi: 10.1097/MAT.0b013e3181d89160.

    PMID: 20404719BACKGROUND
  • Pickering TG, Hall JE, Appel LJ, Falkner BE, Graves J, Hill MN, Jones DW, Kurtz T, Sheps SG, Roccella EJ; Subcommittee of Professional and Public Education of the American Heart Association Council on High Blood Pressure Research. Recommendations for blood pressure measurement in humans and experimental animals: Part 1: blood pressure measurement in humans: a statement for professionals from the Subcommittee of Professional and Public Education of the American Heart Association Council on High Blood Pressure Research. Hypertension. 2005 Jan;45(1):142-61. doi: 10.1161/01.HYP.0000150859.47929.8e. Epub 2004 Dec 20.

    PMID: 15611362BACKGROUND

Study Officials

  • Jürgen Floege, M.D.

    RWTH Aachen University

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NON RANDOMIZED
Masking
NONE
Purpose
DIAGNOSTIC
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

September 30, 2016

First Posted

October 14, 2016

Study Start

October 1, 2016

Primary Completion

May 8, 2020

Study Completion

May 8, 2020

Last Updated

March 24, 2021

Record last verified: 2021-03

Data Sharing

IPD Sharing
Will not share

Locations